Gnosis Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2005.
2005 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Gnosis Pharmaceuticals Private Limited

Gnosis Pharmaceuticals Private Limited, a active private limited company, was established on 17 March 2005 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL2005PTC134162. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.57 Cr.

Formerly known as Kaizen Healthcare Private Limited. It upholds a compliant status. Employing 309 professional, Its leadership includes Ramesh Khurana (Director), Rajesh Kumar Khurana (Director), Surendra Kumar Yadav (Director). Past directors included Shiv Kumar Arora, Mool Chandra Sonkar, Raj Kumar Khurana. It holds ₹30.33 Cr open charges and ₹15.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. B-102 First Floor Pushpanjali Enclave Pitampura, New Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL2005PTC134162

  • Registration Number

    134162

  • Incorporation Date

    17 March 2005

  • Authorized Capital

    ₹1.75 Cr

  • Paid-Up Capital

    ₹1.57 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.75 Cr
  • Paid Up Capital ₹ 1.57 Cr
  • Company Age 20 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 30.33 Cr
  • Satisfied Charges ₹ 15.48 Cr
  • Revenue Growth **** 18.21%
  • Profit Growth **** 143.33%
  • Ebitda **** 34.63%
  • Net Worth 20.44%
  • Total Assets **** 38.20%
Company report

Gnosis Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gnosis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Gnosis Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramesh Khurana Director 26 Nov 2011 Current
Rajesh Kumar Khurana Director 26 Nov 2011 Current
Surendra Kumar Yadav Director 26 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Additional Director 25 Nov 2021 Past
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Director 28 Nov 2011 Past
Pramod Abcsdd Director 01 Apr 2013 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gnosis Pharmaceuticals.

Gnosis Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 18.21% increase. The company also saw a substantial improvement in profitability, with a 143.33% increase in profit. The company's net worth Soared by an impressive increase of 20.44%.

Gnosis Pharmaceuticals revenue growth over time
Gnosis Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 18.21%
*******
*******
*******
*******
Revenue from Operations
*******
 18.35%
*******
*******
*******
*******
Total Assets
*******
 38.20%
*******
*******
*******
*******
Profit or Loss
*******
 143.33%
*******
*******
*******
*******
Net Worth
*******
 20.44%
*******
*******
*******
*******
EBITDA
*******
 34.63%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gnosis Pharmaceuticals?

In 2024, Gnosis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹303,338,000.00

Satisfied Charges

₹154,782,386.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 28.95 Cr
  • Tata Capital Housing Finance Limited : 1.08 Cr
  • Director Of Industries : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
07 Mar 2024 Hdfc Bank Limited ₹2.00 M Open
10 Dec 2021 Hdfc Bank Limited ₹2.50 M Open
10 Dec 2021 Hdfc Bank Limited ₹2.50 M Open
21 Nov 2020 Hdfc Bank Limited ₹28.25 Cr Open
13 Jul 2018 Tata Capital Housing Finance Limited ₹1.08 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Gnosis Pharmaceuticals?

Gnosis Pharmaceuticals has a workforce of 309 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gnosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnosis Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gnosis Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Gnosis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 28.25 Cr registered on 21 Nov 2020 with Charge ID 100418138 was modified on 19 Aug 2024. was recorded as a recent event.

  • Director Appointment

    The activity Surendra Kumar Yadav was appointed as a Director was appointed as a Director on 26 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Balance Sheet

    Progress on Gnosis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100880638 was registered on 07 Mar 2024. was completed.

  • Charges

    The activity A charge registered on 29 May 2019 via Charge ID 100270199 with Others was fully satisfied on 01 Mar 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gnosis Pharmaceuticals Private Limited?

The CIN of Gnosis Pharmaceuticals Private Limited is U24231DL2005PTC134162.

Where is Gnosis Pharmaceuticals Private Limited headquartered?

Gnosis Pharmaceuticals Private Limited is headquartered at House No. B-102 First Floor Pushpanjali Enclave Pitampura, New Delhi, Delhi, 110034.

When was Gnosis Pharmaceuticals Private Limited incorporated?

Gnosis Pharmaceuticals Private Limited was incorporated on 17 March 2005.

Who are the current directors of Gnosis Pharmaceuticals Private Limited?

The current directors of Gnosis Pharmaceuticals Private Limited are

What is the primary industry of Gnosis Pharmaceuticals Private Limited?

The primary industry of Gnosis Pharmaceuticals Private Limited is Manufacturing.

Is Gnosis Pharmaceuticals Private Limited a listed company?

Gnosis Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Gnosis Pharmaceuticals Private Limited?

The authorized capital of Gnosis Pharmaceuticals Private Limited is ₹1.75 Cr, and the paid-up capital is ₹1.57 Cr.

What is the compliance status of Gnosis Pharmaceuticals Private Limited?

The compliance status of Gnosis Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available